NCT00033358View on ClinicalTrials.gov

Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

October 31, 2007

Conditions
Endometrial Cancer
Interventions
DRUG

medroxyprogesterone

Given intramuscularly

DRUG

ethinyl estradiol

Given orally

DRUG

norgestrel

Given orally

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00033358 - Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer | Biotech Hunter | Biotech Hunter